THE PECULIAR BINDING-PROPERTIES OF 4'-DEOXY,4'-IODODOXORUBICIN TO ISOLATED DNA AND 175-BP NUCLEOSOMES

被引:4
作者
CERA, C
PALUMBO, M
机构
[1] UNIV PADUA,DEPT PHARMACEUT SCI,VIA MARZOLO 5,I-35131 PADUA,ITALY
[2] UNIV CAGLIARI,DEPT PHARM CHEM & TECHNOL,I-09100 CAGLIARI,ITALY
关键词
D O I
10.1093/nar/19.20.5707
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The thermodynamic parameters governing the interaction of 4'-deoxy,4'-iododoxorubicin (4'-IAM) to double stranded DNA or 175 bp nucleosomes have been evaluated at different ionic strength and temperature conditions by means of fluorescence techniques. The iodo-anthracycline exhibits quite different characteristics from the parent compounds adriamycin (AM) and daunomycin (DM) and other second generation derivatives. In fact, the contribution of electrostatic interactions to the total free energy of binding is rather poor and the changes in enthalpy, usually high and negative, are low and eventually positive. Unlike other members of its family, 4'-IAM exhibits preference for the nucleosomal structure. In addition, its binding to isolated DNA is remarkably cooperative. Circular dichroism studies show changes in the geometry of the intercalation complex when the drug binds to nucleosomes. The possibility for the iodo-sugar moiety to act as an alkylating or free-radical producing species was also considered as an alternative mechanism of action. However, no evidence was obtained to support these hypotheses. Thus the major differences observed in DNA-binding in comparison to parent anthracyclines appear to be mostly related to the lower pK(a) and higher lipophilicity exhibited by 4'-IAM.
引用
收藏
页码:5707 / 5711
页数:5
相关论文
共 29 条
[1]   ANTITUMOR ANTHRACYCLINES - RECENT DEVELOPMENTS [J].
ARCAMONE, F .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (02) :153-188
[2]  
Arcamone F., 1981, DOXORUBICIN ANTICANC
[3]  
BARBIERI B, 1987, CANCER RES, V47, P4001
[4]   SEQUENCE-SELECTIVE TOPOISOMERASE-II INHIBITION BY ANTHRACYCLINE DERIVATIVES IN SV40 DNA - RELATIONSHIP WITH DNA-BINDING AFFINITY AND CYTOTOXICITY [J].
CAPRANICO, G ;
ZUNINO, F ;
KOHN, KW ;
POMMIER, Y .
BIOCHEMISTRY, 1990, 29 (02) :562-569
[5]   INTERACTION BETWEEN 2ND GENERATION ANTHRACYCLINES AND DNA IN THE NUCLEOSOMAL STRUCTURE [J].
CERA, C ;
PALU, G ;
MAGNO, SM ;
PALUMBO, M .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2309-2314
[6]   BINDING OF DAUNOMYCIN TO CALF THYMUS NUCLEOSOMES [J].
CHAIRES, JB ;
DATTAGUPTA, N ;
CROTHERS, DM .
BIOCHEMISTRY, 1983, 22 (02) :284-292
[7]  
DIMARCO A, 1975, ANTIBIOTICS, V3, P101
[8]   ON THE MECHANISM OF REDUCTIVE ACTIVATION IN THE MODE OF ACTION OF SOME ANTICANCER DRUGS [J].
FAVAUDON, V .
BIOCHIMIE, 1982, 64 (07) :457-475
[9]   COMPARISON OF THE BINDING OF ANTHRACYCLINE DERIVATIVES TO PURIFIED DNA AND TO CELL-NUCLEI [J].
FREZARD, F ;
GARNIERSUILLEROT, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1036 (02) :121-127
[10]   MEMBRANE TARGETS IN CANCER-CHEMOTHERAPY [J].
HICKMAN, JA ;
SCANLON, KJ ;
TRITTON, TR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (01) :15-17